Antithrombotic Medications and Intraocular Hemorrhage Risk in Exudative Age-Related Macular Degeneration

Is the use of anticoagulants or antiplatelets associated with intraocular hemorrhage in age-related macular degeneration?In this cohort study of 149 620 patients with exudative age-related macular degeneration, the use of anticoagulants or antiplatelets was associated with intraocular hemorrhage requiring vitrectomy. The highest risk was observed with the combination of anticoagulants and antiplatelets, and high medication adherence was associated with increased odds of hemorrhage.These findings suggest that patients with age-related macular degeneration should receive proactive communication and monitoring to minimize the threat of intraocular hemorrhage.

Corresponding Author: Se Joon Woo, MD, PhD, Department of Ophthalmology, Seoul National University Bundang Hospital, 173-82 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, South Korea (sejoon1@snu.ac.kr).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.